Drug Search Results
More Filters [+]

Sarcolysin

Alternative Names: sarcolysin
Latest Update: 2025-02-07
Latest Update Note: Clinical Trial Update

Product Description

St. Jude Children's Research Hospital is developing sarcolysin as an anticancer medicine. It is a type of chemotherapy that works by slowing or stopping growth of cancer cells. It may be used to help prepare patients for hematopoietic cell transplant. (Sourced from: https://together.stjude.org/en-us/diagnosis-treatment/medicines-list/melphalan.html)

Mechanisms of Action: Alkylating Agent

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Russia

Approved Indications: None

Known Adverse Events: None

Company: City of Hope Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sarcolysin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Ganglioneuroblastoma|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Acute Lymphoid Leukemia|Myelodysplastic Syndrome|Acute Myeloid Leukemia|Neuroblastoma|Preleukemia

Phase 2: Graft vs Host Disease|Lymphoma|Crohn Disease|Leukemia|Multiple Myeloma|Preleukemia|Melanoma|Myelodysplastic Syndrome|Blast Crisis|Myeloid, Accelerated Leukemia|Acute Myeloid Leukemia|Acute Myelomonocytic Leukemia|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Chronic Myeloid Leukemia|Anemia, Refractory, with Excess of Blasts|Leukemia, Plasma Cell|Hodgkin Lymphoma|Acute Monocytic Leukemia|Neuroblastoma|Chronic Myelomonocytic Leukemia|Juvenile Myelomonocytic Leukemia,|Paroxysmal Hemoglobinuria|Myeloproliferative Disorders|Acute Lymphoid Leukemia|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|B-Cell Leukemia|Sarcoma, Myeloid|Lymphoma, Non-Hodgkin|Lymphoma, B-Cell|Prolymphocytic Leukemia|Chronic Lymphoid Leukemia|Anemia, Aplastic|Myelodysplastic-Myeloproliferative Diseases|Lymphocytic Chronic B-Cell Leukemia|HIV Infections|Mantle-Cell Lymphoma|Large-Cell Immunoblastic Lymphoma|Burkitt Lymphoma|Prolymphocytic B-Cell Leukemia|Thrombocythemia, Essential|Thrombocytosis|T-Cell Lymphoma|Adult T-Cell Leukemia-Lymphoma|Biphenotypic Acute Leukemia|Follicular Lymphoma|Prolymphocytic T-Cell Leukemia|Plasmablastic Lymphoma|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Waldenstrom Macroglobulinemia|Histiocytosis, Langerhans-Cell|Myelofibrosis|Polycythemia Vera

Phase 1: Wilms Tumor|Rhabdomyosarcoma|Blast Crisis|Lymphoma, Non-Hodgkin|Adenomyoepithelioma|Rhabdoid Tumor|Melanoma|Acute Myeloid Leukemia|Renal Cell Carcinoma|Clear Cell Sarcoma|Lymphoma|Neuroblastoma|Gastrointestinal Cancer|Leukemia, Plasma Cell|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Lymphoma, B-Cell|Clear Cell Adenocarcinoma|Chronic Myeloid Leukemia|Myeloproliferative Disorders|Sarcoma, Ewing|Myelodysplastic Syndrome|Juvenile Myelomonocytic Leukemia,|Acute Myelomonocytic Leukemia|Acute Lymphoid Leukemia|Anemia, Aplastic|Preleukemia|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Chronic Lymphoid Leukemia|Multiple Myeloma|Chronic Myelomonocytic Leukemia|Myeloid, Accelerated Leukemia|Lymphocytic Chronic B-Cell Leukemia|Acute Monocytic Leukemia|Biphenotypic Acute Leukemia|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCI-2023-08530

P3

Recruiting

Ganglioneuroblastoma

2029-12-31

ASCT2031

P3

Recruiting

Myelodysplastic Syndrome|Acute Myeloid Leukemia|Preleukemia|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Acute Lymphoid Leukemia

2027-12-01

PRO11090340

P2

Recruiting

Crohn Disease

2025-12-01

NCI-2016-00584

P2

Recruiting

Lymphoma, Non-Hodgkin|Myelodysplastic Syndrome|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Myeloproliferative Disorders|B-Cell Leukemia|Leukemia, Plasma Cell|Chronic Lymphoid Leukemia|Anemia, Refractory, with Excess of Blasts|Acute Monocytic Leukemia|Acute Lymphoid Leukemia|Acute Myeloid Leukemia|Biphenotypic Acute Leukemia|Myeloid, Accelerated Leukemia|Acute Myelomonocytic Leukemia|Juvenile Myelomonocytic Leukemia,|Lymphoma, B-Cell|Chronic Myeloid Leukemia|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|Preleukemia|Multiple Myeloma|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Chronic Myelomonocytic Leukemia|Myelodysplastic-Myeloproliferative Diseases

2025-05-31

Recent News Events